Kerala Orders Probe Into Six Nipah Deaths Over Alleged Expired Remdesivir

The Kerala state government has ordered a detailed inquiry into the deaths of six individuals suffering from the Nipah virus. The probe was initiated following serious allegations that these patients were treated with expired batches of remdesivir, a medication often used in the management of viral infections.

The controversy has raised urgent questions regarding the supply chain and quality control of critical medicines in the state’s healthcare facilities. Authorities are now scrutinizing the records to determine if the expired medication was administered in error or due to a lapse in storage and inventory management protocols.

While the final findings of the investigation are pending, the move underscores the government's commitment to accountability in public health emergencies. The inquiry aims to establish the exact circumstances surrounding the treatment of the deceased patients and to identify any systemic failures that may have contributed to the tragedy.

This incident has sparked broader discussions about the availability and regulation of antiviral drugs in India, particularly in the context of emerging infectious diseases. Health officials are expected to review existing guidelines for drug storage and distribution to prevent similar issues in the future.